
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), …